S. Betty Yan - Concepedia

Author

S. Betty Yan

Eli Lilly (United States)

Also Known As

S B Yan, S Betty Yan, S. B. Yan, S. Betty Yan, S. Yan, S.B Yan, S.B. YAN, S.B. Yan, S.Betty Yan, S. Betty Yan

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Université Paris Cité Assistance Publique – Hôpitaux de Paris Maternité Port Royal Vanderbilt University

About

S. Betty Yan is an author at Eli Lilly (United States) specializing in medicine, cell signaling, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.6K
2	Biochemistry	5	5	125
3	Natural Sciences	4	4	141
4	Engineering	2	2	32
5	Social Sciences	1	1	45

S. Betty Yan

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation J. F. Dhainaut, S. Betty Yan, David E. Joyce, Journal of Thrombosis and Haemostasis ThrombosisSevere SepsisHematologyIntravascular CoagulationSepsis	2004	427
Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569] Gary T. Kinasewitz, S. Betty Yan, Bruce R. Basson, Critical Care	2004	362
Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis Gordon R. Bernard, E. Wesley Ely, Theressa J. Wright, Critical Care Medicine	2001	271
Low Levels of Protein C Are Associated With Poor Outcome in Severe Sepsis S. Betty Yan, Jeffrey D. Helterbrand, Daniel Hartman, CHEST Journal InflammationSevere SepsisPoor OutcomeDisease PathophysiologyInflammatory Marker	2001	257
Human Protein C inhibits selectin-mediated cell adhesion: role of unique fucosylated oligosaccharide Brian W. Grinnell, Róbert Hermann, S. Betty Yan Glycobiology Cell AdhesionImmunologyGlycobiologyCellular PhysiologyInflammation	1994	229
Coagulopathy After Successful Cardiopulmonary Resuscitation Following Cardiac Arrest Christophe Adrie, Mehran Monchi, Ivan Laurent, Journal of the American College of Cardiology Trauma ResuscitationCardiopulmonary ResuscitationMedicinePrehospital ResuscitationCardiology	2005	207
Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications Rolf M. Mesters, Jeff Helterbrand, Barbara G. Utterback, Critical Care Medicine	2000	202
Systemic Host Responses in Severe Sepsis Analyzed by Causative Microorganism and Treatment Effects of Drotrecogin Alfa (Activated) Steven M. Opal, Gary Garber, Steven P. LaRosa, Clinical Infectious Diseases	2003	190
Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia Bryce A. Kerlin, S. Betty Yan, Berend Isermann, Blood	2003	169
LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models S. Betty Yan, Victoria L. Peek, Rose T. Ajamie, Investigational New Drugs	2012	159

Page 1